WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

ASSESSMENT OF RATIONALITY OF FIXED DOSED COMBINATIONS (FDCs) PRESCRIBED IN MEDICINE OUTPATIENT DEPARTMENT OF A TERTIARY HEALTHCARE INSTITUTE

Dr. Abhilasha Rashmi*, Dr. Sudhir Pawar, Dr. Swapnil Jamdade and Dr. Pranesh Pawaskar

ABSTRACT

Background: Fixed Dose Combinations (FDCs) are defined by WHO as combination of two or more active ingredients in a fixed ratio of doses. As the risk-benefit assessment is essential before choosing a combination therapy, this study was done about the presence of CDSCO/ WHO listed FDCs in the OPD prescriptions and their rationality assessment. Methods: It was done by the Department of Pharmacology from September 2017 to February 2018. All prescriptions from Medicine OPD of a tertiary healthcare hospital were screened for FDCs. Each FDC was checked for its presence in recent CDSCO and WHO essential medicines list. Parameters recorded were- 1. Name of combination drugs with doses. 2. Drug class. 3. Year of approval by CDSCO. 4. Rational/ Semi rational/ Irrational based on Rationality Scoring Scale. Rationality assessment was done according to standard reference books. Drug interactions were checked by the “Drug Interaction Checker” provided by www.webmd.com. Results: Number of prescriptions analysed were 700, in which 241 (34.4%) FDCs were present. Due to repetitions, actually 31 categories of FDCs were found. Out of these, 25.8% were rational, 70.9% semi rational and 3.3% irrational. 67.7% were approved while 32.3% not approved by DCGI. 80.9% of them were approved after the year 2000 and rest before that. Among the nonapproved FDCs, 20% were rational and 80% semi rational. Conclusions: Though the prevalence of FDCs in the prescriptions is high, only about 26% of them fulfil the rationality criteria. About 68% FDCs were DCGI approved while 32% were not. Hence, drug regulatory bodies should take urgent action to stop the free flow of irrational FDCs and to encourage rational FDCs.

Keywords: Fixed dose combinations, Rationality scoring scale, Rational, Semi rational, Irrational.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More